Scientists gave middle-aged mice a drug called rapamycin for just 3 months and found it changed their gut bacteria, lowered cancer risk signs, and helped them live longer - proving you don't need long treatment to see benefits.

1

Pro

0

Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

Transient and late-life rapamycin for healthspan extension

Narrative Review

2020 Mar 12

This study tested whether short-term rapamycin treatment (instead of lifelong treatment) can still extend healthspan and lifespan in mice, which matches the claim that only 3 months of treatment is needed for benefits.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Transient and late-life rapamycin for healthspan extension

Score: 1

DOI: 10.18632/aging.102947

Similar Assertions

Giving old mice rapamycin in their food when they're about 60 in human years helps them live longer - males lived 13% longer and females 9% longer on average.

18

0

80%

Scientists gave mice a drug called rapamycin when they were middle-aged (around 270 days old) and found that both male and female mice lived longer compared to mice that didn't get the drug.

18

0

79%

Giving mice the drug rapamycin makes them live longer, but not because it stops particular diseases. Instead, it seems to slow down the basic aging process itself.

18

0

78%

A drug called rapamycin helped mice live longer - males lived about 9% longer and females lived about 14% longer when they started taking the drug in late adulthood.

18

1

78%

A drug called rapamycin helps mice live longer, and scientists have confirmed this works in three different labs - the results show both male and female mice benefit.

18

0

77%